Get started
Author

Mamaev An

Observed names: A N Mamaev, A. Mamaev, A. N. Mamaev, A.N. Mamaev, Andrey Mamaev, Andrey N. Mamaev, А. N. Mamaev, А. N. Маmаеv, А. Н. Мамаев, А.Н. Мамаев
Observed institutions: Altai State Medical University, Russian Academy of Sciences, Belorusneft (Belarus), National Medical Research Center for Hematology, Ministry of Health of the Russian Federation, Pacific Institute of Bioorganic Chemistry. GB Elyakova Far Eastern Branch of the Russian Academy of Sciences, Regional Public Health Care Institution "City Hospital No. 5, Barnaul", Regional State Budget Health Care Institution "Regional Clinical Hospital"
ORCID: 0000-0002-3313-7295
Observed ORCID: 0000-0002-3313-7295
OpenAlex ID: A5067740133
Anticoagulant Activity of Fucoidan from Brown Algae Fucus evanescens of the Okhotsk Sea
2003 · T. A. Kuznetsova, N. N. Besednova, et al. · Bulletin of Experimental Biology and Medicine · 78
Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery
2018 · F. Peyvandi, A. Mamaev, et al. · Journal of Thrombosis and Haemostasis · 75
PDF
Screening of the Promising Direct Thrombin Inhibitors from Haematophagous Organisms. Part I: Recombinant Analogues and Their Antithrombotic Activity In Vitro
2021 · Maria A. Kostromina, Elena A. Tukhovskaya, et al. · Biomedicines · 12
PDF
Changes in systemic inflammatory and hemostatic response in patients with co-morbidity of exacerbation of chronic obstructive pulmonary disease, chronic heart failure and obesity
2014 · A. G. Chuchalin, I. Ya. Tseymakh, et al. · PULMONOLOGIYA · 8
PDF
[Immunostimulating and anticoagulating activity of fucoidan from brown algae Fucus evanescens of Okhotskoe sea].
2003 · T A Kuznetsova, T S Zaporozhets, et al. · PubMed · 7
[thrombogenic Risk Factors in Patients With Exacerbation of Chronic Obstructive Pulmonary Disease].
2015 · A G Chuchalin, I Ya Tseimakh, et al. · PubMed · 5
Management of patients with hemophilia A on emicizumab prophylactic treatment: Recommendation from Russian Experts
2022 · T. A. Andreeva, P. A. Zharkov, et al. · Гематология и трансфузиология · 4
PDF
Assessment of hemostasis in physiological pregnancy. Algorithms of examination in high risk groups. Guidelines (PROJECT), 2nd edition
2019 · А.П. Момот, М.Г. Николаева, et al. · Тромбоз гемостаз и реология · 4
Non-plasmin fibrinolysis with immobilized subtilisins
2019 · П.Г. Мадонов, А.П. Момот, et al. · Тромбоз гемостаз и реология · 4
Parenteral Viral Hepatitis in People With Hemophilia: Ways to Solve the Problem
2019 · M.A. Nikonorova, N.V. Karbysheva, et al. · Bulletin of Medical Science · 4
Thrombotic events in rare kinds of genetic thrombophilias
2020 · М.Г. Николаева, А.П. Момот, et al. · Тромбоз гемостаз и реология · 3
[Role of endothelial dysfunction, the interface between hemostatic and system inflammatory responses in the pathogenesis of an infectious inflammation-dependent exacerbation of chronic obstructive pulmonary disease].
2013 · I Ia Tseĭmakh, A P Momot, et al. · PubMed · 3
Pharmacotherapy of Massive Obstetric Bleedings as Alternative to Hysterectomy
2012 · Andrey Momot, Irina Molchanova, et al. · InTech eBooks · 3
PDF
A sorbent modified with melatonin and lithium: in vitro investigation of the effect on hemostatic reactions
2024 · A. P. Momot, L. N. Rachkovskaya, et al. · Сибирский научный медицинский журнал · 2
PDF
Lithium-Modified Sorbent: Effects on Hemostatic Responses In Vitro
2023 · L. N. Rachkovskaya, A. P. Momot, et al. · Bulletin of Experimental Biology and Medicine · 2
Minimally invasive mitral valve repair and ablation of concomitant atrial fibrillation in a patient with severe hemophilia A
2021 · Alexander Bogachev‐Prokophiev, Ravil Sharifulin, et al. · Clinical Case Reports · 2
PDF
Laboratory support for assessing the hemostatic system in a physiologically proceeding pregnancy, in risk groups for the development of thrombosis and gestational complications: expert opinion
2019 · T. V. Vavilova, A. P. Momot, et al. · Laboratory Service · 2
Results of a multicenter, prospective, open, uncontrolled study of the efficacy and safety of the drug Innonafactor in patients aged 12 years and older with severe and moderate hemophilia B
2017 · T. A. Andreeva, I. L. Davydkin, et al. · Russian Journal of Pediatric Hematology and Oncology · 2
PDF
Современные аспекты патогенеза, диагностики и терапии ДВС-синдрома
2008 · А. П. Момот, Mamaev An · Клиническая онкогематология. Фундаментальные исследования и клиническая практика · 2
Platelet Delta granules storage pool deficiency in female patient with severe hemorrhagic syndrome
2023 · I. V. Kosheed, A. N. Mamaev, et al. · Гематология и трансфузиология · 1
PDF
Bleeding disorders associated with severity of respiratory failure in COVID-19 patients: a prospective observational study
2023 · Mikhail I. Neymark, A. P. Momot, et al. · Annals of critical care · 1
PDF
Impact of correction of homocisteinemia on clinical outcomes of lung damage associated with COVID-19 coronavirus infection
2023 · I. Ya. Tseimakh, D. E. Bogachev, et al. · Bulletin physiology and pathology of respiration · 1
PDF
Advancing Plasma D-dimer Level Determination: an Applicability Analysis for Covid-19 Patients at the Hospital Stage
2023 · Dmitry A. Momot, Andrey N. Mamaev, et al. · Bulletin of Medical Science · 1
PDF
Results of the Open Multicenter Prospective Clinical Study of the Efficacy, Safety, and Pharmacokinetics of Moroctocog Alpha in 6 to 12 Year Old Children With Hemophilia a
2021 · M.A. Timofeeva, T.A. Andreeva, et al. · PEDIATRIA Journal named after G N SPERANSKY · 1
The results of the use of Octofactor in patients with moderate and severe hemophilia A (data from a prospective, multicenter, open-label, observational study)
2019 · N. I. Zozulya, O. I. Yastrubinetskaya, et al. · Russian Journal of Pediatric Hematology and Oncology · 1
PDF
Works count: 62
Citation count: 232
H-index: 5
I10-index: 3
Year
Topic
Type